EU medtech notified bodies face code compliance audits
This article was originally published in Clinica
The association of EU medtech notified bodies, Team-NB, has completed an audit – the first of its kind – to check whether its member companies are following the association's code of conduct. Though no enforcement deficiencies were found in the first round of audits that was completed on 16 December, the audits will continue in 2014 and beyond to keep medical device notified bodies on their toes.
You may also be interested in...
Citing challenges posed by the COVID-19 pandemic, EU regulators have extended the deadline for companies to finish nitrosamine-related risk evaluations.
The Australian health care products regulator is inviting feedback on proposed measures to clarify the boundary for software-based products that are captured under the regulatory framework for medical devices.
A draft EU guideline explains how companies can ensure that data from ongoing clinical trials remains relevant for regulatory decision-making despite problems posed by the COVID-19 pandemic.